210 related articles for article (PubMed ID: 27542221)
1. Acetylation of FOXM1 is essential for its transactivation and tumor growth stimulation.
Lv C; Zhao G; Sun X; Wang P; Xie N; Luo J; Tong T
Oncotarget; 2016 Sep; 7(37):60366-60382. PubMed ID: 27542221
[TBL] [Abstract][Full Text] [Related]
2. Metadherin/Astrocyte elevated gene-1 positively regulates the stability and function of forkhead box M1 during tumorigenesis.
Yang L; He K; Yan S; Yang Y; Gao X; Zhang M; Xia Z; Huang Z; Huang S; Zhang N
Neuro Oncol; 2017 Mar; 19(3):352-363. PubMed ID: 27923917
[TBL] [Abstract][Full Text] [Related]
3. SIRT1 deacetylates the DNA methyltransferase 1 (DNMT1) protein and alters its activities.
Peng L; Yuan Z; Ling H; Fukasawa K; Robertson K; Olashaw N; Koomen J; Chen J; Lane WS; Seto E
Mol Cell Biol; 2011 Dec; 31(23):4720-34. PubMed ID: 21947282
[TBL] [Abstract][Full Text] [Related]
4. FXR acetylation is normally dynamically regulated by p300 and SIRT1 but constitutively elevated in metabolic disease states.
Kemper JK; Xiao Z; Ponugoti B; Miao J; Fang S; Kanamaluru D; Tsang S; Wu SY; Chiang CM; Veenstra TD
Cell Metab; 2009 Nov; 10(5):392-404. PubMed ID: 19883617
[TBL] [Abstract][Full Text] [Related]
5. Homeodomain interacting protein kinase-2 phosphorylates FOXM1 and promotes FOXM1-mediated tumor growth in renal cell carcinoma.
Liu F; Li N; Liu Y; Zhang J; Zhang J; Wang Z
J Cell Biochem; 2019 Jun; 120(6):10391-10401. PubMed ID: 30609136
[TBL] [Abstract][Full Text] [Related]
6. O-GlcNAcylation regulates breast cancer metastasis via SIRT1 modulation of FOXM1 pathway.
Ferrer CM; Lu TY; Bacigalupa ZA; Katsetos CD; Sinclair DA; Reginato MJ
Oncogene; 2017 Jan; 36(4):559-569. PubMed ID: 27345396
[TBL] [Abstract][Full Text] [Related]
7. HMGA1 promotes breast cancer angiogenesis supporting the stability, nuclear localization and transcriptional activity of FOXM1.
Zanin R; Pegoraro S; Ros G; Ciani Y; Piazza S; Bossi F; Bulla R; Zennaro C; Tonon F; Lazarevic D; Stupka E; Sgarra R; Manfioletti G
J Exp Clin Cancer Res; 2019 Jul; 38(1):313. PubMed ID: 31311575
[TBL] [Abstract][Full Text] [Related]
8. Set7/9 impacts COL2A1 expression through binding and repression of SirT1 histone deacetylation.
Oppenheimer H; Kumar A; Meir H; Schwartz I; Zini A; Haze A; Kandel L; Mattan Y; Liebergall M; Dvir-Ginzberg M
J Bone Miner Res; 2014 Feb; 29(2):348-60. PubMed ID: 23873758
[TBL] [Abstract][Full Text] [Related]
9. Sirt1 deacetylates c-Myc and promotes c-Myc/Max association.
Mao B; Zhao G; Lv X; Chen HZ; Xue Z; Yang B; Liu DP; Liang CC
Int J Biochem Cell Biol; 2011 Nov; 43(11):1573-81. PubMed ID: 21807113
[TBL] [Abstract][Full Text] [Related]
10. FOXM1 (Forkhead box M1) in tumorigenesis: overexpression in human cancer, implication in tumorigenesis, oncogenic functions, tumor-suppressive properties, and target of anticancer therapy.
Wierstra I
Adv Cancer Res; 2013; 119():191-419. PubMed ID: 23870513
[TBL] [Abstract][Full Text] [Related]
11. Elevated expression of FoxM1 promotes the tumor cell proliferation in hepatocellular carcinoma.
Yu M; Tang Z; Meng F; Tai M; Zhang J; Wang R; Liu C; Wu Q
Tumour Biol; 2016 Jan; 37(1):1289-97. PubMed ID: 26289845
[TBL] [Abstract][Full Text] [Related]
12. Expression of FOXM1 and related proteins in breast cancer molecular subtypes.
Lee JJ; Lee HJ; Son BH; Kim SB; Ahn JH; Ahn SD; Cho EY; Gong G
Int J Exp Pathol; 2016 Apr; 97(2):170-7. PubMed ID: 27277416
[TBL] [Abstract][Full Text] [Related]
13. FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells.
Hamurcu Z; Ashour A; Kahraman N; Ozpolat B
Oncotarget; 2016 Mar; 7(13):16619-35. PubMed ID: 26918606
[TBL] [Abstract][Full Text] [Related]
14. Histone deacetylase inhibitors synergize p300 autoacetylation that regulates its transactivation activity and complex formation.
Stiehl DP; Fath DM; Liang D; Jiang Y; Sang N
Cancer Res; 2007 Mar; 67(5):2256-2264. PubMed ID: 17332356
[TBL] [Abstract][Full Text] [Related]
15. Sirtuin 1 modulates cellular responses to hypoxia by deacetylating hypoxia-inducible factor 1alpha.
Lim JH; Lee YM; Chun YS; Chen J; Kim JE; Park JW
Mol Cell; 2010 Jun; 38(6):864-78. PubMed ID: 20620956
[TBL] [Abstract][Full Text] [Related]
16. The transcription factor FOXM1 (Forkhead box M1): proliferation-specific expression, transcription factor function, target genes, mouse models, and normal biological roles.
Wierstra I
Adv Cancer Res; 2013; 118():97-398. PubMed ID: 23768511
[TBL] [Abstract][Full Text] [Related]
17. Lipopolysaccharide modulates p300 and Sirt1 to promote PRMT1 stability via an SCF
Lai Y; Li J; Li X; Zou C
J Cell Sci; 2017 Oct; 130(20):3578-3587. PubMed ID: 28883095
[TBL] [Abstract][Full Text] [Related]
18. Interplay between protein acetylation and ubiquitination controls MCL1 protein stability.
Shimizu K; Gi M; Suzuki S; North BJ; Watahiki A; Fukumoto S; Asara JM; Tokunaga F; Wei W; Inuzuka H
Cell Rep; 2021 Nov; 37(6):109988. PubMed ID: 34758305
[TBL] [Abstract][Full Text] [Related]
19. Acetylation of lysine 109 modulates pregnane X receptor DNA binding and transcriptional activity.
Pasquel D; Doricakova A; Li H; Kortagere S; Krasowski MD; Biswas A; Walton WG; Redinbo MR; Dvorak Z; Mani S
Biochim Biophys Acta; 2016 Sep; 1859(9):1155-1169. PubMed ID: 26855179
[TBL] [Abstract][Full Text] [Related]
20. Epigenetically modulated FOXM1 suppresses dendritic cell maturation in pancreatic cancer and colon cancer.
Zhou Z; Chen H; Xie R; Wang H; Li S; Xu Q; Xu N; Cheng Q; Qian Y; Huang R; Shao Z; Xiang M
Mol Oncol; 2019 Apr; 13(4):873-893. PubMed ID: 30628173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
